Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Ovarian Carcinosarcoma
• Ovarian Epithelial Cancer
• Ovarian Sarcoma
• Uterine Carcinosarcoma
• Uterine Leiomyosarcoma
• Uterine Sarcoma

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Female Reproductive Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-11-21